Immutep Ltd Adr Stock Performance
| IMMP Stock | USD 2.03 0.04 2.01% |
The company retains a Market Volatility (i.e., Beta) of 0.64, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immutep's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immutep is expected to be smaller as well. At this point, Immutep Ltd ADR has a negative expected return of -0.29%. Please make sure to check out Immutep's potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Immutep Ltd ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return 2.01 | Five Day Return 2.01 | Year To Date Return (13.62) | Ten Year Return (33.88) | All Time Return (94.94) |
Last Split Factor 3:10 | Dividend Date 2016-12-28 | Last Split Date 2016-12-28 |
1 | Dow Jumps Over 200 Points NY Empire State Manufacturing Index Increases In September | 09/16/2024 |
2 | FIL Ltd Acquires New Stake in Immutep Ltd | 11/12/2024 |
3 | Immuteps Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer | 11/14/2024 |
| Begin Period Cash Flow | 123.4 M |
Immutep |
Immutep Relative Risk vs. Return Landscape
If you would invest 253.00 in Immutep Ltd ADR on September 1, 2024 and sell it today you would lose (50.00) from holding Immutep Ltd ADR or give up 19.76% of portfolio value over 90 days. Immutep Ltd ADR is currently does not generate positive expected returns and assumes 3.4032% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Immutep, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Immutep Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Immutep Ltd ADR, and traders can use it to determine the average amount a Immutep's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0856
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMMP |
Estimated Market Risk
| 3.4 actual daily | 30 70% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immutep is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immutep by adding Immutep to a well-diversified portfolio.
Immutep Fundamentals Growth
Immutep Stock prices reflect investors' perceptions of the future prospects and financial health of Immutep, and Immutep fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immutep Stock performance.
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (13.53) % | ||||
| Current Valuation | 175.22 M | ||||
| Shares Outstanding | 145.46 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 2.36 X | ||||
| Price To Sales | 80.30 X | ||||
| Revenue | 3.84 M | ||||
| Gross Profit | (32.75 M) | ||||
| EBITDA | (44.54 M) | ||||
| Net Income | (42.72 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (34.82 M) | ||||
| Earnings Per Share | (0.24) X | ||||
| Market Capitalization | 308.51 M | ||||
| Total Asset | 201.58 M | ||||
| Retained Earnings | (382.65 M) | ||||
| Working Capital | 125.19 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
About Immutep Performance
Assessing Immutep's fundamental ratios provides investors with valuable insights into Immutep's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Immutep is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.26) | (0.27) | |
| Return On Capital Employed | (0.29) | (0.31) | |
| Return On Assets | (0.24) | (0.26) | |
| Return On Equity | (0.26) | (0.28) |
Things to note about Immutep Ltd ADR performance evaluation
Checking the ongoing alerts about Immutep for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immutep Ltd ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Immutep Ltd ADR generated a negative expected return over the last 90 days | |
| Immutep Ltd ADR has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 3.84 M. Net Loss for the year was (42.72 M) with loss before overhead, payroll, taxes, and interest of (32.75 M). | |
| Immutep Ltd ADR currently holds about 80 M in cash with (34.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. | |
| Immutep Ltd ADR has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Immuteps Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer |
- Analyzing Immutep's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immutep's stock is overvalued or undervalued compared to its peers.
- Examining Immutep's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Immutep's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immutep's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Immutep's stock. These opinions can provide insight into Immutep's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.